HIGHLIGHTS
- who: CXCL et al. from the Department of Obstetrics and Gynecology, Te Tird Afliated Hospital of Zhengzhou University, Zhengzhou, China have published the research work: EphA2 Promotes the Development of Cervical Cancer through the CXCL11/PD-L1 Pathway, in the Journal: Journal of Oncology 1.5 Relative mRNA expression (Fold change) of 28/Nov/2022
- what: The study demonstrated that EphA2 plays a tumor-promoting role in cervical carcinoma through the providing new guidance for the targeted therapy and combination therapy of cervical carcinoma.
- how: Relevant experimental results showed that the expression level . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.